Skip to content
Home
Anna Weiss, M.D.

Anna Weiss, M.D.

Contact

Appointment (585) 487-1700

About Me

Faculty Appointments

Associate Professor - Department of Surgery, Oncology (SMD)

Associate Professor - Cancer Center - Joint

Credentials

Post-doctoral Training & Residency

Fellowship, Surgery, Breast, University of Texas MD Anderson Cancer Center. 2016 - 2017

Internship, Surgery (General Surgery), University of California San Diego-General Surgery. 2008 - 2009

Residency, Internship/Residency, University of California San Diego-General Surgery. 2008 - 2016

Education

MD | Case Western Reserve University. 2008

Awards

Early Career Women Faculty Leadership Development Seminar, Association of American Medical Colleges, Applied and accepted for le. 2021

Best Manuscript Award, Association of Women Surgeons. 2018

Conquer Cancer Merit Award American Society of Clinical Oncology (ASCO) Research, outstanding poster by a trainee. 2017

Corynee S. Uhl Award, MD Anderson Cancer Center, For excellence and compassionate breast cancer patient care. 2017

American College of Surgeons Leadership and Advocacy Summit Resident and Associate Society of ACS, Travel Grant to attend the Su. 2016

Jeopardy Contestant and Winner, San Diego Chapter of the American College of Surgeons (ACS). 2015

Outstanding Clinical/Outcomes Research Award, Surgery Research Showcase, UCSD. 2014

Grant award to fund "Breaking the Glass Ceiling: A Dinner Symposium"Chancellor's Committee on the Status of Women, UCSD, Co-chai. 2012

Award for Research Excellence at Lepow Day, AOA, Case Western Reserve University. 2006

Crile Fellowship, Case Western Reserve University Research in pediatric pulmonology at Rainbow Babies and Children's Hospital,. 2005

Training Grant Cystic Fibrosis Foundation, Research in pediatric pulmonology at Rainbow Babies and Children's Hospital. 2005

Josephine E. and Kenneth M. Schreck, MD Family Endowment Fund Annual Scholarship Award, Case Western Reserve University, School. 2004 - 2008

Research

Clinical Trials

OptimICE-PCR: De-Escalation of Therapy in Early-Stage TNBC Patients Who Achieve pCR After Neoadjuvant Chemotherapy With Checkpoint Inhibitor Therapy

Lead Researcher: Anna Weiss

The phase III trial compares the effect of pembrolizumab to observation for the treatment of patients with early-stage triple-negative breast cancer who achieved a pathologic complete response after preoperative chemotherapy in combination with pembr...

Locations

875 Hard Rd
Webster, NY 14580-8949